 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Eloralintide for Sale > New peptide Eloralintide

New peptide Eloralintide buy - large image1

New peptide Eloralintide

ISO COA 45 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2883634-40-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Packaging:

Vial/bag

Price valid (until):

2026-02-16

Contact Supplier

 Chat Now

NATURE INDUSTRIAL LIMITED

Company Type:

Trader

Location:

Hongkong, China

Qualification:

Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Description

New Eloralintide/606723/S018 2883634-40-8 for weigth loss

Eloralintide (LY 3841136) is an AMYR agonist, which is promising for research of type 2 diabetes and obesity.

Eloralintide is a long-acting amylin receptor agonist and structural analog of the natural hormone amylin, which is co-secreted with insulin by pancreatic β-cells. It has been developed as a potent metabolic modulator that mimics the physiological effects of amylin, including appetite regulation and glucose control.

Items	Specifications
M.Wt	4526.10
Formula	C201H319N49O65S2
Chemical Name/SMILES	Sequence: {γGlu}-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gly-{Orn}-Leu-Ala-Glu-{(α-Me-Phe)}-Leu-Val-Arg-Ser-Ser-Asn-{(N-Me-Asn)}-Phe-Gly-Pro-{Lys(γGlu-γGlu-C20 diacid)}-Leu-Pro-Pro-Thr-Glu-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (Methylene bridge: Cys2-Cys7)

Items	Standard		Test Results
Identification	A.H-NMR:Comply with the structure		Complies
	B.LC-MS:Comply with the structure		Complies
	C.The IR spectrum of sample should be identical with that of reference standard.		Complies
	D.HPLC-ESI-MS The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.		Complies
Loss on drying %	≤2.0		0.19
Heavy metals ppm	≤10		<10
Moisture %	≤1.0		0.1
Sulphated ash %	≤0.5 determined on 1.0 g.		0.009
Residue on ignition %	≤0.1		0.03
Related Substances %	Unspecified impurities: for each impurity	≤0.10	<0.10
Related Substances %	Total Impurity	≤0.5	0.18
Purity %	≥99.0		99.7
Assay %	99.0 ~101.0 (anhydrous substance).		99.8
Storage	Preserve in well-closed, light-resistant and airtight containers.		Complies

FAQ

Q1: When will the product be shipped after payment?
  ---We are committed to the same day shipping.

Q2. How does your factory control quality?
All the raw material purchasing and production quality control are strictly following the ISO9001: 2008 management system. Besides, the full-featured detection equipment and GMP quality management system provided the strongest guarantee for a high-quality product.

Q3: How long will it take to receive the parcel?
   --3 days for the US market; 4-6 days for the others.

Q4: What can I do if I don't have the ability to clear the custom?
   --We got experience after doing export for many years, so don't worry we can handle that.

Q5: Can I get some samples?
---Yes.

Contact us if you want to order online.

ECHEMI Editorial Reference

Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

Certificates

Basic Info

Product Name:

Eloralintide

Other Name:

Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

CAS No.:

2883634-40-8

Molecular Weight:

EC Number:

262-076-3

Color/Form:

White to off-white

Categories:

Bulk Drug Intermediates

Research

Class:

Amylin receptor (AMYR) agonist (peptide, long-acting)

Status:

Investigational — Phase 1/2 (T2DM and obesity)

Mechanism:

Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

Activity note:

Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

Source:

MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

References

PubChem:

PubChem

Literature:

MCE: Eloralintide (CAS 2883634-40-8); AbMole: Eloralintide (LY 3841136)

Disclaimer:

Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

Seller Information

Business Type:
Trader

Main Products:
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

Location:
Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
7

Total Annual Revenue:
$50 million-$100 million

Total Employees:
51-100

Year of Establishment:
2012

We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

"Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

Inquiry History

45 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	Eloralintide	1 KG	May 28, 2026
United States	Eloralintide	5 MT	Aug 10, 2026
United States	Eloralintide	10 MG	Aug 3, 2026
United States	eloralintide	1 PCS	Jul 26, 2026
Australia	Eloralintide	15 MG	Jul 20, 2026
United States	Eloralintide	1 MT	Jul 15, 2026
United States	Eloralintide	20 MG	Jul 13, 2026
United States	Eloralintide	1	Jul 4, 2026
United States	Eloralintide	100 MT	Jun 29, 2026
United States	Elorintide	15 MG	Jun 15, 2026
United States	(LY3841136)	1000 MG	Jun 8, 2026
Australia	Eloralintide	100 MT	May 8, 2026
Thailand	Eloralintide	2 G	Mar 30, 2026
United States	Eloralintide	3	Mar 9, 2026
United States	Eloralintide	2 G	Feb 7, 2026
United States	Eloralintide	10 PCS	Nov 11, 2025
United States	eloralintide	2 PCS	Aug 2, 2026
United States	eloralintide	30 MG	Jul 28, 2026
United States	Elora	32 G	Jul 27, 2026
United States	Eloralintide	1 G	Jul 13, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Eloralintide cas: 2883634-40-8 Not For Human Use, Lab Use Only.	Pharmaceutical Grade/99		Hangzhou Go Top Peptide Biotech Co.,Ltd.	Inquiry
Eloralintide, LY3841136, 2883634-40-8	Reagent Grade/98	$1000-1200/G FOB	cellmano peptide	Inquiry
Eloralintide CAS 2883634-40-8 LY3841136 AMY1176 Peptide Raw Powder 98% Purity	Pharmaceutical Grade/99		Hangzhou Hyper Chemicals Limited	Inquiry
High Purity Eloralintide Powder CAS No. 2703710-13-6 Weight Management API	Pharmaceutical Grade/95	$73.5-84/G FOB	Arshine Group Co., Ltd.	Inquiry
Eloralintide 10G High Quality Shaanxi Dideu Medichem Co.Ltd	Pharmaceutical Grade/98		Shaanxi Dideu Medichem Co. Ltd	Inquiry

New peptide Eloralintide

Product Description

Seller Information

Inquiry History

More Choices Find All Products for Sale 

Related Searches